Related Experiment Video
Updated: Jul 16, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Complement in lupus nephritis: the good, the bad, and the unknown
1Section of Nephrology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA. lbao@medicine.bsd.uchicago.edu
The complement system plays a dual role in systemic lupus erythematosus (SLE). While early complement proteins are protective, later activation is harmful, offering therapeutic targets for SLE.
Area of Science:
- Immunology
- Rheumatology
Background:
- The complement system, comprising over 30 proteins and 3 pathways, regulates immune responses but can paradoxically contribute to disease.
- Hereditary deficiencies in early complement components increase SLE risk, yet complement activation is evident in active disease.
- Mouse models have been crucial for understanding SLE pathogenesis and testing complement-targeted therapies.
Purpose of the Study:
- To elucidate the complex role of the complement system in systemic lupus erythematosus (SLE) pathogenesis.
- To investigate the protective versus proinflammatory functions of different complement pathway components.
- To evaluate the therapeutic potential of complement inhibitors in SLE.
Main Methods:
- Utilized genetically modified mouse models of SLE to study complement's role.
- Examined the effects of early complement proteins (C1q, C4) and later pathway activation.
- Assessed the safety and efficacy of complement inhibitors like soluble complement receptor 1 and anti-C5 antibody.
Main Results:
- Confirmed that early complement proteins (C1q, C4) are protective in SLE.
- Demonstrated that complement activation later in the cascade is proinflammatory and detrimental.
- Identified complement inhibitors (TP10, Eculizumab) that safely modulate complement activity.
Conclusions:
- The complement system's role in SLE is complex, with early components being protective and later activation being pathogenic.
- Complement inhibitors show promise for treating lupus nephritis, but clinical trials face challenges.
- Targeting specific complement pathways offers a potential therapeutic strategy for SLE management.
Related Concept Videos
Complement System
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome III : Nursing Management
Hypersensitivity Reactions: Immune-Complex Reactions